MedTrace Logo

The Effect of β-hydroxy-β-methylbutyrate Supplementation on Physical Capacity and Body Composition in Trained Athletes

NCT03028649 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2017-01-23

No results posted yet for this study

Summary

The purpose of this study was to verify the effect of 12-week with β-hydroxy-β-methylbutyrate (HMB) and a placebo (PLA) supplementation on body composition, anaerobic and aerobic capacity, as well as concentrations of the selected biochemical blood markers in trained athletes, in a randomised, double-blind, placebo-controlled crossover trial.

Conditions

  • Sport
  • Supplements
  • Supplementation

Interventions

DIETARY_SUPPLEMENT

β-hydroxy-β-methylbutyrate and a placebo supplementation

Sponsors & Collaborators

  • Poznan University of Life Sciences

    collaborator OTHER

  • National Science Centre, Poland

    collaborator OTHER_GOV

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Jan Jeszka, Professor · Department of Hygiene and Human Nutrition, Poznan University of Life Sciences, Poznan, Poland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
17 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03028649 on ClinicalTrials.gov